Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date |
Article Title |
Journal |
|---|---|---|---|
|
Fadi S. Dahdaleh, Scott K. Sherman, Elizabeth C. Poli, Janani Vigneswaran, Blase N. Polite, Manish R. Sharma, Daniel V. Catenacci, Steven B. Maron, Kiran K. Turaga |
October 2018 | Obstruction Predicts Worse Long-term Outcomes in Stage III Colon Cancer: A Secondary Analysis of the N0147 Trial | Surgery |
|
Giorgos Bakoyannis, Dipankar Bandyopadhyay |
November 2021 | Nonparametric tests for multistate processes with clustered data | AISM |
|
Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan J. Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Tarek A. Hammad, Joann Lindenfeld, Martin J. Murphy, Javid Moslehi, On Behalf of the Checkpoint Inhibitor Safety Working Group |
May 2018 | Myocarditis Associated with Immune Checkpoint Inhibitors: an Expert Consensus on Data Gaps and a Call to Action | The Oncologist |
|
Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Terek A. Hammad, Joann Lindenfeld, Martin J. Murphy, Javid Moslehi, On Behalf of the Checkpoint Inhibitor Safety Working Group |
May 2018 | Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action | The Oncologist |
|
Jiawei Zhou, Yutong Liu, Yubo Zhang, Quefeng Li and Yanguang Cao |
November 2019 | Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer; a retrospective analysis | American Association for Cancer Research |
|
Louis Dron, Shirin Golchi, Grace Hsu, Kristian, Thorlund |
September 2019 | Minimizing Control Group Allocation in Randomized Trials Using Dynamic Borrowing of External Control Data – An Application to Second Line Therapy for Non-Small Cell Lung Cancer | Contemporary Clinical Trials Communications |
|
Farees Saqlain, Sophia Z. Shalhout, Kevin S. Emerick, Tomas G. Neilan, Tatyana Sharova, David Michael Miller |
September 2020 | Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events | Case Reports in Dermatological Medicine |
| September 2017 | Merck to co-lead new oncology big data alliance | PMLiVE | |
|
CEO Roundtable on Cancer |
November 2020 | Merck KGaA, Darmstadt, Germany, Recognized for Collaborative Cancer Research by CEO Roundtable on Cancer | PR Newswire |
|
Kentaro Matsuura, Jun Tsuchida, Shuji Ando, Takashi Sozu |
March 2021 | Matrix decomposition in meta‐analysis for extraction of adverse event pattern and patient‐level safety profile | Pharmaceutical Statistics |
|
Felix D. Beacher, Lilianne R. Mujica-Parodi , Shreyash Gupta and Leonardo A. Ancora |
May 2021 | Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer | Algorithms |
|
Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes-Rivera, Mei-Yin C Polley, Fahar Merchant, Lauren E Abrey, Joshua E Allen, Laura K Aguilar, Estuardo Aguilar-Cordova, David Arons, Kirk Tanner, Stephen Bagley, Mustafa Khasraw, Prof Timothy Cloughesy, Prof Patrick Y Wen, Brian M Alexander, Lorenzo Trippa |
September 2021 | Leveraging external data in the design and analysis of clinical trials in neuro-oncology | Lancet Oncology |
|
Siddharth Ramchandran, Gleb Tikhonov, Otto Lönnroth, Pekka Tiikkainen, Harri Lähdesmäki |
March 2022 | Learning Conditional Variational Autoencoders with Missing Covariates | arXiv |
|
Patrick M. Cotogno, Lahiru K. Ranasinghe, Elisa M. Ledet, Brian E. Lewis, Oliver Sartor |
April 2018 | Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer | The Oncologist |
